<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>24630578</identifier>
<setSpec>1578-1852</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Guna Serrano, María del Remedio</dc:author>
<dc:author>Latorre Martínez, José-Carlos</dc:author>
<dc:author>Orta Mira, Nieves</dc:author>
<dc:author>Gimeno Cardona, Concepción</dc:author>
<dc:author>Ovies, María Rosario</dc:author>
<dc:author>Ruiz de Gopegui, Enrique</dc:author>
<dc:author>Poveda, Marta</dc:author>
<dc:description xml:lang="en">Human immunodeficiency virus type 1 (HIV-1) and hepatitis B (HBV) and C virus (HCV) viral load determinations are among the most relevant markers for the follow up of patients infected with these viruses. External quality control tools are crucial to ensure the accuracy of results obtained by microbiology laboratories. This article summarized the results obtained from the 2012 SEIMC External Quality Control Programme for HIV-1, HCV, and HBV viral loads. In the HIV-1 program, a total of five standards were sent. One standard consisted in seronegative human plasma, while the remaining four contained plasma from three different viremic patients, in the range of 2-5 log10 copies/mL; two of these standards were identical aiming to determine repeatability. A significant proportion of the laboratories (22.3% on average) obtained values out of the accepted range (mean±0.25 log10 copies/mL), depending on the standard and on the method used for quantification. Repeatability was excellent, with up to 98.9% of laboratories reporting results within the limits (Δ &lt; 0.5 log10 copias/mL). The HBV and HCV program consisted of two standards with different viral load contents. Most of the participants, 84% in the case of HCV and 88% in the HBV, obtained all the results within the accepted range (mean±1.96 SD log10 UI/mL). Data from this analysis reinforce the utility of proficiency programmes to ensure the quality of the results obtained by a particular laboratory, as well as the importance of the post-analytical phase on the overall quality. Due to the remarkable interlaboratory variability, it is advisable to use the same method and the same laboratory for patient follow up.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:subject>Carga viral</dc:subject>
<dc:subject>HIV-1</dc:subject>
<dc:subject>Proficiency</dc:subject>
<dc:subject>VHC</dc:subject>
<dc:subject>Intercomparación</dc:subject>
<dc:subject>VHB</dc:subject>
<dc:subject>VIH-1</dc:subject>
<dc:subject>HCV</dc:subject>
<dc:subject>Control de calidad externo</dc:subject>
<dc:subject>HBV</dc:subject>
<dc:subject>Viral load</dc:subject>
<dc:subject>External quality control</dc:subject>
<dc:date>2014 Feb </dc:date>
<dc:title xml:lang="es">Análisis de resultados del Programa de Control de Calidad Externo de carga viral del VIH-1, del VHC y del VHB. Año 2012.</dc:title>
<dc:title xml:lang="en">[Analysis of the results of the HIV-1, HCV and HBV viral load of SEIMC External Quality Control Program. Year 2012].</dc:title>
<dc:publisher>Enfermedades infecciosas y microbiologia clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
